Rationale & Objective:
The extent of recovery of kidney function following acute kidney injury (AKI) is known to be associated with future chronic kidney disease. Less is known about how the timing of recovery affects the rate of future loss of kidney function.
Study Design:
We performed a retrospective cohort study examining the independent association between the timing of recovery from moderate to severe AKI and future loss of kidney function.
Setting & Participants:
47,903 adult US veterans with stage 2 or 3 AKI who recovered to within 120% of baseline creatinine level within 90 days of peak injury.
Exposure:
The timing of recovery of kidney function from peak inpatient serum creatinine level grouped into 1 to 4, 5 to 10, 11 to 30, and 31 to 90 days.
Outcome:
A sustained 40% decline in estimated glomerular filtration rate below that calculated from the last serum creatinine level available during the 90-day recovery period or kidney failure (2 outpatient estimated glomerular filtration rates<15mL/min/1.73m, dialysis procedures > 90 days apart, kidney transplantation, or registry within the US Renal Data System).
Analytical Approach:
Time to the primary outcome was examined using multivariable Cox proportional hazards regression.
Results:
Among 47,903 patients, 29,316 (61%), 10,360 (22%), 4,520 (9%), and 3,707 (8%) recovered within 1 to 4, 5 to 10, 11 to 30, and 31 to 90 days, respectively. With a median follow-up of 42 months, unadjusted incidence rates for the kidney outcome were 2.01, 3.55, 3.86, and 3.68 events/100 person-years, respectively. Compared with 1 to 4 days, recovery within 5 to 10, 11 to 30, and 31 to 90 days was associated with increased rates of the primary outcome: adjusted HRs were 1.33 (95% CI, 1.24-1.43), 1.41 (95% CI, 1.28-1.54), and 1.58 (95% CI, 1.43-1.75), respectively.
Limitations:
Predominately male population, residual confounding, and inability to make causal inferences because of the retrospective observational study design.
Conclusions:
The timing of recovery provides an added dimension to AKI phenotyping and prognostic information regarding the future occurrence of loss of kidney function. Studies to identify effective interventions on the timing of recovery from AKI are warranted.
Citing Articles
Outcome in Critically Ill Dogs and Dogs With Acute Kidney Injury Based on Neutrophil Gelatinase-Associated Lipocalin and Tissue Inhibitor of Metalloproteinase-2.
Dorn E, Biscop A, Devriendt N, Castelain D, Demeyere K, Stock E
J Vet Intern Med. 2025; 39(2):e70024.
PMID: 40008829
PMC: 11863212.
DOI: 10.1111/jvim.70024.
Predictive Factors for Onset of Moderate-to-Severe Disability Following Hospital Discharge Due to Rib Fractures.
Granados Santiago M, Lopez Lopez L, Quero Valenzuela F, Calvache Mateo A, Martin Nunez J, Ortiz Rubio A
Healthcare (Basel). 2024; 12(19).
PMID: 39408163
PMC: 11476026.
DOI: 10.3390/healthcare12191984.
Development and validation of a predictive model for acute kidney injury in patients with ureterolithiasis.
Jiang Y, Zhang J, Ainiwaer A, Liu Y, Li J, Zhou L
Ren Fail. 2024; 46(2):2394634.
PMID: 39177235
PMC: 11346321.
DOI: 10.1080/0886022X.2024.2394634.
Effect of rehabilitation on renal outcomes after acute kidney injury associated with cardiovascular disease: a retrospective analysis.
Hirano Y, Fujikura T, Kono K, Yamaguchi T, Ohashi N, Yokoyama Y
BMC Nephrol. 2024; 25(1):222.
PMID: 38997657
PMC: 11242010.
DOI: 10.1186/s12882-024-03666-z.
The Road to Precision Medicine for Acute Kidney Injury.
Birkelo B, Koyner J, Ostermann M, Bhatraju P
Crit Care Med. 2024; 52(7):1127-1137.
PMID: 38869385
PMC: 11250999.
DOI: 10.1097/CCM.0000000000006328.
Acute Kidney Injury Duration and 20-Year Risks of CKD and Cardiovascular Disease.
Jensen S, Heide-Jorgensen U, Gammelager H, Birn H, Christiansen C
Kidney Int Rep. 2024; 9(4):817-829.
PMID: 38765592
PMC: 11101785.
DOI: 10.1016/j.ekir.2024.01.034.
A study of hospitalized COVID-19 patients with AKI in a setting of multiracial developing country.
Ooi S, Ng K, Sthaneshwar P, Lim S, Khor P, Lim J
BMC Nephrol. 2024; 25(1):122.
PMID: 38580977
PMC: 10998399.
DOI: 10.1186/s12882-024-03498-x.
Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysis.
Hsiao C, Pan H, Wu V, Su C, Yeh T, Chuang M
Front Med (Lausanne). 2023; 10:1252990.
PMID: 37795409
PMC: 10547056.
DOI: 10.3389/fmed.2023.1252990.
Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.
Mitrea L, Medeleanu M, Pop C, Rotar A, Vodnar D
Toxins (Basel). 2023; 15(9).
PMID: 37755974
PMC: 10535688.
DOI: 10.3390/toxins15090548.
Probiotics in septic acute kidney injury, a double blind, randomized control trial.
Chavez-Iniguez J, Ibarra-Estrada M, Gallardo-Gonzalez A, Cisneros-Hernandez A, Claure-Del Granado R, Chavez-Alonso G
Ren Fail. 2023; 45(2):2260003.
PMID: 37724527
PMC: 10512773.
DOI: 10.1080/0886022X.2023.2260003.
The use of anti-adrenergic agents as a predictor of acute kidney injury and delayed recovery of kidney function: the NARA-AKI cohort study.
Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima K
Hypertens Res. 2023; 46(11):2470-2477.
PMID: 37369848
DOI: 10.1038/s41440-023-01352-5.
Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation.
Voigtlander-Buschmann L, Schafer S, Schmidt-Lauber C, Weimann J, Shenas M, Giraldo Cortes J
Clin Res Cardiol. 2023; 113(6):801-811.
PMID: 37264143
PMC: 11108912.
DOI: 10.1007/s00392-023-02234-z.
Risk factors for development of acute kidney injury and acute kidney disease in critically ill children.
Hui W, Chan V, Cheung W, Ku S, Hon K
J Nephrol. 2023; 36(5):1425-1434.
PMID: 37060439
DOI: 10.1007/s40620-023-01613-z.
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup.
Zarbock A, Nadim M, Pickkers P, Gomez H, Bell S, Joannidis M
Nat Rev Nephrol. 2023; 19(6):401-417.
PMID: 36823168
DOI: 10.1038/s41581-023-00683-3.
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
Tiu B, Strohbehn I, Zhao S, Ouyang T, Hanna P, Wang Q
Oncologist. 2023; 28(6):e379-e390.
PMID: 36821637
PMC: 10243781.
DOI: 10.1093/oncolo/oyad001.
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice.
Lim L, Chow E, Chan J
Nat Rev Endocrinol. 2022; 19(3):151-163.
PMID: 36446898
DOI: 10.1038/s41574-022-00776-2.
Kidney Function Trajectory within Six Months after Acute Kidney Injury Inpatient Care and Subsequent Adverse Kidney Outcomes: A Retrospective Cohort Study.
Tain Y, Liu C, Kuo H, Hsu C
J Pers Med. 2022; 12(10).
PMID: 36294745
PMC: 9605305.
DOI: 10.3390/jpm12101606.
Circulating and urinary microRNAs profile for predicting renal recovery from severe acute kidney injury.
Phulkerd T, Lertussavavivat T, Limothai U, Peerapornratana S, Kulvichit W, Lumlertgul N
J Intensive Care. 2022; 10(1):45.
PMID: 36180946
PMC: 9523985.
DOI: 10.1186/s40560-022-00637-0.
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Coca S, Vasquez-Rios G, Mansour S, Moledina D, Thiessen-Philbrook H, Wurfel M
Am J Kidney Dis. 2022; 81(2):190-200.
PMID: 36108888
PMC: 9868060.
DOI: 10.1053/j.ajkd.2022.08.007.
Subphenotypes in acute kidney injury: a narrative review.
Vaara S, Bhatraju P, Stanski N, McMahon B, Liu K, Joannidis M
Crit Care. 2022; 26(1):251.
PMID: 35986336
PMC: 9389711.
DOI: 10.1186/s13054-022-04121-x.